                Figure 3.  Fate mapping of lymph node T cells with the transgenic HY-TCR using RORγt-cre.CD4 and CD8α expression by gated HY (T3.70)+ lymph node cells (left column) is shown in the second column. EYFP expression by HY+CD4−CD8α−, HY+CD4+CD8α− and HY+CD4−CD8α+ T cells is shown.

